1,3-dipropyl-8-cyclopentylxanthine has been researched along with ascorbic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constantino, MD; Oliveira, JC; Ribeiro, JA; Sebastião, AM | 1 |
| Agostinho, P; Caseiro, P; Cunha, RA; Duarte, EP; Oliveira, CR; Rego, AC | 1 |
| Golab, F; Katebi, M; Mehdizadeh, M; Mohamadzadeh, F; Soleimani, M; Zamani, M | 1 |
3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and ascorbic acid
| Article | Year |
|---|---|
Ascorbate/Fe(3+)-induced peroxidation and inhibition of the binding of A1 adenosine receptor ligands in rat brain membranes.
Topics: Animals; Ascorbic Acid; Binding Sites; Brain; Ferric Compounds; Guanosine Triphosphate; Ligands; Lipid Peroxides; Male; Membranes; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1995 |
Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
Topics: Adenosine; Adenosine Deaminase; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Cells, Cultured; Chick Embryo; Drug Synergism; Kinetics; Oxidative Stress; Phenethylamines; Potassium; Potassium Chloride; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Retina; Theobromine; Tritium; Xanthines | 2000 |
NeuroProtective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Antioxidants; Ascorbic Acid; Avoidance Learning; bcl-2-Associated X Protein; Behavior, Animal; Blotting, Western; CA1 Region, Hippocampal; In Situ Nick-End Labeling; Male; Maze Learning; Memory, Short-Term; Mice; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Receptors, Purinergic P1; Reperfusion Injury; Xanthines | 2013 |